Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eee0ac4068fa6498c461357f460e0a29 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 |
filingDate |
2010-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ce57e6f6243bca9e416ccf2696b3c82 |
publicationDate |
2012-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20120118516-A |
titleOfInvention |
Human anti-epithelial growth factor receptor FA antibody and pharmaceutical composition for tumor treatment comprising the same |
abstract |
The present invention relates to human anti-epithelial growth factor receptor Fab antibodies. In the present invention, the high-affinity anti-EGFR human Fab antibody selected by the DVS-II method includes a heavy chain variable region and a light chain variable region selected by screening, thereby specificizing the epidermal growth factor receptor. As a result, it is possible to provide a pharmaceutical composition for treating tumors and a pharmaceutical composition for treating rectal cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016171365-A1 |
priorityDate |
2010-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |